JARED WHITEHEAD: Open Payments
NPI 1528356367 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 37 payments from 15 companies in 2025. Trend: 2023 $1,401 · 2024 $563 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $121 |
| Ardelyx, Inc. | 4 | $67 |
| ABBVIE INC. | 4 | $66 |
| Novo Nordisk Inc | 3 | $50 |
| Lilly USA, LLC | 2 | $38 |
| Dexcom, Inc. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Lundbeck LLC | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: Auvelity, CAPLYTA, IBSRELA, QULIPTA, MOUNJARO, Dexcom G6 Transmitter, GVOKE HYPOPEN, REXULTI.
Industry payments across LA — which companies pay providers there.
